Abstract
A case of systemic infection due to Saprochaete capitata in a patient with chronic lymphocytic leukemia is described. A review of the literature was conducted to identify all reported cases of this infection described between 1977 and August 2013. One hundred and four cases (included the present one) were identified. The median age of the patients was 56 years and 56 % were males. Comorbidities included acute myeloid leukemia (52 %), acute lymphoid leukemia (22 %), other hematological malignancies (13 %) and non-hematological diseases (9 %). At the time of the infection, 82 % of the patients were neutropenic. In 75 % of the cases, the yeast was isolated from blood culture, in 25 % from other sterile sites. Empirical treatment was done in 36 % of the cases. Fifty-eight percent of the individual cases were treated with a combination or a sequential antifungal therapy. Amphotericin B was the antifungal drug most commonly used, followed by voriconazole and itraconazole. The overall crude mortality was 60 %. Saprochaete capitata causes life-threatening infections in neutropenic patients. This comprehensive literature review may help the clinician to optimize the management of this rare infection.
This is a preview of subscription content, log in via an institution to check access.
References
Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O, et al. ESCMID/ECMM joint clinical guideline for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2013;. doi:10.1111/1469-0691.12360.
Krcmery V, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukemia. J Hosp Infect. 1999;41:181–94.
Bouza E, Munoz P. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin Microbiol Infect. 2004;10:76–85.
Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis. 1996;22:112–8.
Groll AH, Walsh TJ. Uncommon opportunistic fungi: new nosocomial threats. Clin Microbiol Infect. 2001;7:8–24.
Nucci M, Marr KA, Vehreschild MJ, de Souza CA, Velasco E, Cappellano P, et al. Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect. 2013;. doi:10.1111/1469-0691.12409.
Walsh TJ, Gamaletsou MN. Treatment of fungal disease in the setting of neutropenia. Hematology Am Soc Hematol Educ Program. 2013;2013:423–7.
Etienne A, Datry A, Gaspar N, Morel V, Delabesse E, Lmimouni B, et al. Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient. Mycoses. 2008;51:270–2.
Fianchi L, Montini L, Caira M, Voso MT, Maviglia R, Posteraro B, et al. Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient. Infection. 2008;36:65–7.
Chittick P, Palavecino EL, Delashmitt B, Evans J, Peacock JE. Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrob Agents Chemother. 2009;53:5306–7.
Schuermans C, van Bergen M, Coorevits L, Verhaegen J, Lagrou K, Surmont I, et al. Breakthrough Saprochaete capitata in patients receiving echinocandins: case report and review of the literature. Med Mycol. 2011;49:414–8.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mazzocato, S., Marchionni, E., Fothergill, A.W. et al. Epidemiology and outcome of systemic infections due to saprochaete capitata: case report and review of the literature. Infection 43, 211–215 (2015). https://doi.org/10.1007/s15010-014-0668-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-014-0668-3